Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SRDX save search
Surmodics Reports First Quarter Fiscal 2021 Results
Published: 2021-02-09 (Crawled : 13:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 2.05%
H: 16.16%
C: 11.68%
results report
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
Published: 2023-03-28 (Crawled : 14:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.47%
H: 15.62%
C: 13.85%
approval update application
Medical Device Coating Market to be Worth $23.85 Billion by 2030: Grand View Research, Inc.
Published: 2023-03-28 (Crawled : 16:00) - prnewswire.com
SOTK | $4.2199 -3.17% 2.1K
|
Manufacturing
|
| O: 1.51%
H: 0.0%
C: -0.29%
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.47%
H: 15.62%
C: 13.85%
device medical market
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
Published: 2023-01-19 (Crawled : 13:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -27.61%
H: 15.21%
C: -2.4%
fda application approval update
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -27.61%
H: 15.21%
C: -2.4%
drug conference platform
Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon
Published: 2023-06-20 (Crawled : 12:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 3.71%
H: 12.69%
C: 11.96%
fda approval
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Published: 2024-02-01 (Crawled : 14:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -3.72%
H: 9.88%
C: -4.34%
first year financial
Next Generation Sequencing (NGS) Market is expected to generate a revenue of USD 49.76 Billion by 2030, Globally, at 20.82% CAGR: Verified Market Research®
Published: 2022-09-16 (Crawled : 14:20) - prnewswire.com
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.75%
H: 7.1%
C: 2.22%
research expected market
Surmodics Announces TRANSCEND Trial 12-Month Data to be Presented at LINC 2021 Virtual Event
Published: 2021-01-12 (Crawled : 15:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 0.62%
H: 6.67%
C: 6.03%
trial
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 4.97%
H: 5.2%
C: 2.28%
year financial
Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery
Published: 2023-04-19 (Crawled : 12:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.39%
H: 4.91%
C: 2.35%
Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26
Published: 2023-04-19 (Crawled : 12:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.39%
H: 4.91%
C: 2.35%
report financial results
Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20
Published: 2023-04-11 (Crawled : 14:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 0.62%
H: 4.72%
C: 3.55%
conference
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
Published: 2023-06-27 (Crawled : 12:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 0.56%
H: 0.13%
C: -0.86%
KRMD | $2.21 3.27% 3.17% 81K
|
Health Technology
|
| O: 0.83%
H: 4.66%
C: -1.37%
medical financial
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
Published: 2022-11-11 (Crawled : 14:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.69%
H: 4.6%
C: 1.3%
trial
Surmodics to Participate in Upcoming Investor Conferences in March
Published: 2023-03-08 (Crawled : 17:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 1.43%
H: 4.58%
C: 2.32%
Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27
Published: 2022-04-19 (Crawled : 13:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: 0.14%
H: 4.29%
C: 3.61%
conference
Biocompatible Coatings Market worth $29.7 billion by 2028 - Exclusive Report by MarketsandMarkets™
Published: 2023-06-22 (Crawled : 08:00) - prnewswire.com
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.17%
H: 4.16%
C: 3.56%
report market
Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
Published: 2022-04-25 (Crawled : 13:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -6.87%
H: 3.52%
C: 0.84%
system symposium
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
Published: 2022-10-11 (Crawled : 13:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.63%
H: 3.43%
C: 1.64%
europe trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.